# Cross-session log — Gate 2 declared, Wave 2 closed — 2026-08-31

PROJECT_ID: `pitavastatin-ezetimibe-evidence` · RUN_ID: `2026-08-31-v1`
Logged by: Research Director (`pit-eze-research-director`)

## Trigger

PI directive: apply the existing Gate 2 authorization (READY_WITH_PENDING_ITEMS given the two
required LlamaParse demonstrations succeeded despite paywalled sources); do not open Wave 3; do not
assume the PI can supply the 6 blocked PDFs — keep them explicit `NEEDS_PI`/`BLOCKED_FOR_SOURCE`;
run the planned Challenge Round and QA on all accessible Wave 2 evidence; update 00–05, 90 logs, and
99_FINAL-QA; verify no PDF/parsed fulltext tracked and no secrets present; commit, push, report Gate
2 status.

## Final incoming specialist reports processed before closure

- **guideline-risk**: #35 obtained (tas.org.tw mirror, article-in-press proof) — 4 primary-prevention
  LDL-C thresholds extracted, flagged distinct from other guidelines' secondary-prevention numbers.
  T-006 and #34 confirmed `BLOCKED_FOR_SOURCE` after exhausting reasonable lawful avenues (correctly
  stopped rather than URL-guessing further). Item 6 closed: 3/5 obtained, 2/5 blocked.
- **safety-pharmacology**: T-009 cluster 4/4 `VERIFIED_MATCH` via Crossref/Europe PMC, with a
  Cochrane-vs-companion-source caveat noted on item 3 and an honest "background-tier only" call on
  item 4.

Both folded into `02_SOURCE-INVENTORY.md` (#34, #35, T-006, T-009 rows updated).

## Actions taken this turn

1. Sent closure notices to all three specialists: Gate 2 declared, no Wave 3, stand by.
2. Conducted a Director-run **Wave 2 Challenge Round** across all four Runbook §30 angles
   (guideline/trials/safety/methods) — written to `30_METHODS/shared/wave2-challenge-round.md`.
   Four priority findings surfaced (Taiwan STS 2026 framing unverified; REPRIEVE/REAL-CAD-to-FDC
   conflation risk; FDC-specific CKD dosing gap; Singh 2024 RCT-vs-observational pooling parallel to
   the Sydhom framing) — none block Gate 2 under the PI's own criteria, all carried into
   `04_OPEN-QUESTIONS.md` for Wave 3.
3. Logged Decision 2026-08-31-27 (Gate 2 declaration, consolidated record).
4. Updated `00_RUN-MANIFEST.md` (gate pointer, non-destructively — historical Wave 0 gate note left
   intact per additive-versioning), `01_RESEARCH-CHARTER.md` (status update appended, original
   Wave-0 uncertainty assessment left intact), `02_SOURCE-INVENTORY.md`, `03_DECISION-LOG.md`,
   `04_OPEN-QUESTIONS.md`, `05_STATUS.md` (Gate 2 formally declared, Wave marked complete).
5. Updated `99_FINAL-QA.md` with a status/context note only — the Final QA Checklist itself remains
   untouched and reserved for the independent auditor (Wave 4, not yet started); the Director does
   not audit its own work.
6. Verified: `git ls-files` shows no `.pdf`/`.parsed.md`/`fulltext/` paths tracked; `git status
   --porcelain --ignored` confirms both the shared and per-role `fulltext/` directories are
   correctly gitignored (`**/20_EVIDENCE/**/fulltext/`, `**/10_DATA/fulltext/`); `git grep` for
   common secret patterns (API keys, bearer tokens, AWS-style keys, password assignments) across all
   tracked files, including `CLAUDE.md`, returned no matches.

## Status

Gate 2: `READY_WITH_PENDING_ITEMS`. Wave 3: not opened. All three specialists idle, standing by. No
further action pending except PI direction on next steps (Wave 3 synthesis, or resolving any of the
six explicitly-blocked sources, or opening Wave 4 audit).
